Literature DB >> 2572700

Neuroleptics and psychic indifference: a review.

D Healy1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572700      PMCID: PMC1292340          DOI: 10.1177/014107688908201018

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  43 in total

1.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  Level of arousal and the subclassification of schizophrenia.

Authors:  P H VENABLES; J K WING
Journal:  Arch Gen Psychiatry       Date:  1962-08

Review 3.  Brain dopamine receptors.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1980-09       Impact factor: 25.468

4.  Studies of depressive symptoms in schizophrenia.

Authors:  D A Johnson
Journal:  Br J Psychiatry       Date:  1981-08       Impact factor: 9.319

5.  Positive and negative schizophrenic symptoms and the role of dopamine.

Authors:  T J Crow
Journal:  Br J Psychiatry       Date:  1980-10       Impact factor: 9.319

6.  The natural history of schizophrenia in the long term.

Authors:  L Ciompi
Journal:  Br J Psychiatry       Date:  1980-05       Impact factor: 9.319

7.  Dopaminergic mechanisms and cognitive deficit in schizophrenia. A neurobiological model.

Authors:  M H Joseph; C D Frith; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

Review 8.  Moods, misattributions and mania: an interaction of biological and psychological factors in the pathogenesis of mania.

Authors:  D Healy; J M Williams
Journal:  Psychiatr Dev       Date:  1989

9.  Cerebrospinal fluid homovanillic acid patterns during neuroleptic treatment.

Authors:  M B Bowers; G R Heninger
Journal:  Psychiatry Res       Date:  1981-06       Impact factor: 3.222

10.  Longitudinal studies of schizophrenic patients.

Authors:  G Huber; G Gross; R Schüttler; M Linz
Journal:  Schizophr Bull       Date:  1980       Impact factor: 9.306

View more
  7 in total

1.  The dopamine antagonist cis-flupenthixol blocks the expression of the conditioned positive but not the negative effects of cocaine in rats.

Authors:  Jennifer M Wenzel; Zu-In Su; Kerisa Shelton; Hiram M Dominguez; Victoria A von Furstenberg; Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2013-09-05       Impact factor: 3.533

2.  Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data.

Authors:  Jemima Thompson; Jacki L Stansfeld; Ruth E Cooper; Nicola Morant; Nadia E Crellin; Joanna Moncrieff
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-24       Impact factor: 4.328

Review 3.  Dopamine and reward: the anhedonia hypothesis 30 years on.

Authors:  Roy A Wise
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 4.  Drug treatment of resistant schizophrenia. Limitations and recommendations.

Authors:  A E Farmer; A Blewett
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 5.  Neuroleptic dysphoria: towards a new synthesis.

Authors:  L Voruganti; A G Awad
Journal:  Psychopharmacology (Berl)       Date:  2003-11-27       Impact factor: 4.530

6.  Positive and Negative Effects of Antipsychotic Medication: An International Online Survey of 832 Recipients.

Authors:  John Read; James Williams
Journal:  Curr Drug Saf       Date:  2019

7.  How do psychiatric drugs work?

Authors:  Joanna Moncrieff; David Cohen
Journal:  BMJ       Date:  2009-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.